- Lipoprotein(a) Reduction With Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors: A Systematic Review and Meta-analysisIoannis, Farmakis; Ioannis, Doundoulakis; Areti, Pagiantza; Stefanos, Zafeiropoulos; Christina, Antza; Haralambos, Karvounis; George, GiannakoulasJournal of Cardiovascular Pharmacology, 2021, 77(3): 397-407.
- Reduction in saturated fat intake for cardiovascular diseaseLee, Hooper; Nicole, Martin; Oluseyi F, Jimoh; Christian, Kirk; Eve, Foster; Asmaa S, AbdelhamidCochrane Database of Systematic Reviews, 2020.被引 4
- Small Dense LDL: New Marker for Cardiovascular Risk Assessment and its Therapeutic InflectionM Salman KhanBiochemistry & Analytical Biochemistry, 2012, 01(06).
期刊论文
Lipoprotein(a) Reduction in Persons with Cardiovascular Disease
1被引17阅读
